Suppr超能文献

自动乳腺动脉钙化评分与心血管结局和死亡率相关。

Automated Breast Arterial Calcification Score Is Associated With Cardiovascular Outcomes and Mortality.

作者信息

Allen Tara Shrout, Bui Quan M, Petersen Gregory M, Mantey Richard, Wang Junhao, Nerlekar Nitesh, Eghtedari Mohammad, Daniels Lori B

机构信息

Division of Preventive Medicine, University of California-San Diego, La Jolla, California, USA.

Division of Cardiovascular Medicine, University of California-San Diego, La Jolla, California, USA.

出版信息

JACC Adv. 2024 Sep 27;3(11):101283. doi: 10.1016/j.jacadv.2024.101283. eCollection 2024 Nov.

Abstract

BACKGROUND

Breast arterial calcification (BAC) on mammograms has emerged as a biomarker of women's cardiovascular disease (CVD) risk, but there is a lack of quantification tools and clinical outcomes studies.

OBJECTIVES

This study assessed the association of BAC (both presence and quantity) with CVD outcomes.

METHODS

This single-center, retrospective study included women with a screening mammogram from 2007 to 2016. BAC was quantified using an artificial intelligence-generated score, which was assessed as both a binary and continuous variable. Regression analyses evaluated the association between BAC and mortality and a composite of acute myocardial infarction, heart failure, stroke, and mortality. Analyses were adjusted for age, race, diabetes, smoking, blood pressure, cholesterol, and history of CVD and chronic kidney disease.

RESULTS

A total of 18,092 women were included in this study (mean age 56.8 ± 11.0 years; diabetes [13%], hypertension [36%], hyperlipidemia [40%], and smoking [5%]). BAC was present in 4,223 (23%). Over a median follow-up of 6 years, death occurred in 7.8% and 2.3% of women with and without BAC, respectively. The composite occurred in 12.4% and 4.3% of women with and without BAC, respectively. Compared to those without, women with BAC had adjusted HRs of 1.49 (95% CI: 1.33-1.67) for mortality and 1.56 (95% CI: 1.41-1.72) for the composite. Each 10-point increase in the BAC score was associated with higher risk of mortality (HR: 1.08 [95% CI: 1.06-1.11]) and the composite (HR: 1.08 [95% CI: 1.06-1.10]). BAC was especially predictive of future events among younger women.

CONCLUSIONS

BAC is independently associated with mortality and CVD, especially among younger women. Measurement of BAC beyond presence adds incremental risk stratification. Quantifying BAC using an artificial intelligence algorithm is feasible, clinically relevant, and may improve personalized CVD risk stratification.

摘要

背景

乳腺钼靶X线片上的乳腺动脉钙化(BAC)已成为女性心血管疾病(CVD)风险的生物标志物,但缺乏量化工具和临床结局研究。

目的

本研究评估了BAC(存在情况和数量)与CVD结局之间的关联。

方法

这项单中心回顾性研究纳入了2007年至2016年期间接受乳腺钼靶筛查的女性。使用人工智能生成的评分对BAC进行量化,该评分被评估为二元变量和连续变量。回归分析评估了BAC与死亡率以及急性心肌梗死、心力衰竭、中风和死亡率的综合指标之间的关联。分析对年龄、种族、糖尿病、吸烟、血压、胆固醇以及CVD和慢性肾病病史进行了校正。

结果

本研究共纳入18,092名女性(平均年龄56.8±11.0岁;糖尿病[13%],高血压[36%],高脂血症[40%],吸烟[5%])。4,223名(23%)女性存在BAC。在中位随访6年期间,有BAC和无BAC的女性死亡率分别为7.8%和2.3%。综合指标在有BAC和无BAC的女性中分别为12.4%和4.3%。与无BAC的女性相比,有BAC的女性校正后死亡率的风险比(HR)为1.49(95%CI:1.33 - 1.67),综合指标的HR为1.56(95%CI:1.41 - 1.72)。BAC评分每增加10分,死亡率(HR:1.08 [95%CI:1.06 - 1.11])和综合指标(HR:1.08 [95%CI:1.06 - 1.10])的风险就越高。BAC对年轻女性未来事件的预测性尤其强。

结论

BAC与死亡率和CVD独立相关,尤其是在年轻女性中。除了检测BAC是否存在外,对其进行测量可增加风险分层。使用人工智能算法量化BAC是可行的、具有临床相关性,并且可能改善个性化的CVD风险分层。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2af/11470245/f6e16b5d985e/ga1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验